Syndeio Biosciences: Funding, Investors & Team (Sep 2026)
Syndeio Biosciences is a biotech company in the clinical stage that is dedicated to creating treatments that can improve and repair synaptic health in disorders of the central nervous system.
Syndeio Biosciences has raised $90.0M across 1 funding round on record, the most recent an undisclosed round of $90.0M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Syndeio Biosciences Company Profile and Key Stats
Latest funding round on record: May 2025.
Syndeio Biosciences Funding Rounds
Syndeio Biosciences Founders and Leadership Team
Contact details for the Syndeio Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Syndeio Biosciences Funding Compared to Other Biotechnology Startups
Syndeio Biosciences' latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Syndeio Biosciences in Biotechnology and Indianapolis
Companies Similar to Syndeio Biosciences
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Syndeio Biosciences Funding FAQs
What does Syndeio Biosciences do?
Syndeio Biosciences is a biotech company in the clinical stage that is dedicated to creating treatments that can improve and repair synaptic health in disorders of the central nervous system.
How much funding has Syndeio Biosciences raised?
Syndeio Biosciences has raised $90.0M across 1 round on record. The most recent is an undisclosed round of $90.0M announced in May 2025.
When did Syndeio Biosciences last raise funding?
Syndeio Biosciences' most recent funding round on record is an undisclosed round of $90.0M, announced in May 2025.
Who founded Syndeio Biosciences?
FundedIQ lists Derek Small (Founder) at Syndeio Biosciences.
Where is Syndeio Biosciences headquartered?
Syndeio Biosciences is based in Indianapolis, Indiana, United States.
How many employees does Syndeio Biosciences have?
Syndeio Biosciences is in the 11-50 employee band.
How does Syndeio Biosciences' funding compare to other Biotechnology startups?
Syndeio Biosciences' latest round of $90.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Syndeio Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Syndeio Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.